| Literature DB >> 34123071 |
Loredana Leone1, Mariangela Boccalon2, Giuseppe Ferrauto3, István Fábián4, Zsolt Baranyai2, Lorenzo Tei1.
Abstract
A current challenge in medical diagnostics is how to obtain high MRI relaxation enhancement using GdIII-based contrast agents (CAs) containing the minimum concentration of GdIII ions. We report that in GdHPDO3A-like complexes a primary amide group located in close proximity to the coordinated hydroxyl group can provide a strong relaxivity enhancement at slightly acidic pH. A maximum relaxivity of r 1 = 9.8 mM-1 s-1 (20 MHz, 298 K) at acidic pH was achieved, which is more than double that of clinically approved MRI contrast agents under identical conditions. This effect was found to strongly depend on the number of amide protons, i.e. it decreases with a secondary amide group and almost completely vanishes with a tertiary amide. This relaxivity enhancement is attributed to an acid-catalyzed proton exchange process between the metal-coordinated OH group, the amide protons and second sphere water molecules. The mechanism and kinetics of the corresponding H+ assisted exchange process are discussed in detail and a novel simultaneous double-site proton exchange mechanism is proposed. Furthermore, 1H and 17O NMR relaxometry, Chemical Exchange Saturation Transfer (CEST) on the corresponding EuIII complexes, and thermodynamic and kinetic studies are reported. These highlight the optimal physico-chemical properties required to achieve high relaxivity with this series of GdIII-complexes. Thus, proton exchange provides an important opportunity to enhance the relaxivity of contrast agents, providing that labile protons close to the paramagnetic center can contribute. This journal is © The Royal Society of Chemistry.Entities:
Year: 2020 PMID: 34123071 PMCID: PMC8163333 DOI: 10.1039/d0sc02174a
Source DB: PubMed Journal: Chem Sci ISSN: 2041-6520 Impact factor: 9.825
Scheme 1The GdIII complexes synthesized and discussed in the present work.
Fig. 1Relaxivity of Gd(HPADO3A) (A), Gd(BzHPADO3A) (B), Gd(PipHPADO3A) (C) and Gd(HPDO3A) (D) as a function of pH ([GdL] = 1.0 mM, 20 MHz, 0.15 M NaCl, 298 K).
Scheme 2Mechanism of the H+ assisted exchange of –OH and –CONH– protons of Gd(HPADO3A). The free rotation around the C2–C3 σ bond of the pendant arm guarantees the same mechanism for both enantiomers at C2.
Fig. 2(A) Z-spectra and (B) ST%-spectra of Eu(HPADO3A) (20 mM) in water at different pH values; (C) ST% effect for Eu(HPADO3A), in water as a function of pH; (D) ST-weighted, CEST map capillaries filled with Eu(HPADO3A) (20 mM) in water at various pH values (1: pH 4.6; 2: pH 5.5; 3: pH 5.9; 4: pH 6.5; 5: pH 6.7; 6: pH 7.0; 7: pH 7.5; 8: water).
Kinetic and relaxation parameters for the proton exchange reactions of the GdIII complexes of HPADO3A, BzHPADO3A and PipHPADO3A compared to Gd(HPDO3A) (20 MHz, 0.15 M NaCl, 298 K)
|
|
|
|
|
|
| |
|---|---|---|---|---|---|---|
| mM−1 s−1 | mM−1 s−1 | s | M−1 s−1 | M−1 s−1 | M−1 s−1 | |
| HPA-DO3A | 4.57 ± 0.07 | 4.32 ± 0.03 | 5.6 ± 0.2 | 2.1 ± 0.2 | — | 1.8 ± 0.3 |
| BzHPA-DO3A | 5.7 ± 0.4 | 0.8 ± 0.2 | — | 2.5 ± 0.5 | ||
| PipHPA-DO3A | 5 ± 1 | 1.0 ± 0.3 | — | 2.3 ± 0.8 | ||
| HP-DO3A | 4.28 ± 0.01 | 4.54 ± 0.03 | 5.0 ± 0.1 | — | 1.0 ± 0.1 | — |
Fig. 31H NMRD profiles of Gd(HPADO3A) (black circles), Gd(Bz-HPADO3A) (red squares) and Gd(pip-HPADO3A) (blue triangles) at pH 4.2 (top) and 7.4 (below).
Selected best-fit parameters obtained from the analysis of the 1/T11H NMRD profiles (298 and 310 K) and 17O NMR data for Gd(HPADO3A), Gd(BzHPADO3A), and Gd(PipHPADO3A)
| Parameter | Gd(HPADO3A) | Gd(BzHPADO3A) | Gd(PipHPADO3A) | |||
|---|---|---|---|---|---|---|
| pH 4.2 | pH 7.4 | pH 4.2 | pH 7.4 | pH 4.2 | pH 7.4 | |
|
| 9.8 (2) | 4.3 (1) | 7.2 (1) | 4.5 (1) | 5.3 (2) | 4.6 (1) |
|
| — | 6.7 (1) | — | 7.7 (1) | — | 8.5 (1) |
|
| 4.99 (2) | — | 2.87 (2) | — | 1.12 (3) | — |
|
| 12.0 (7) | 8.5 (1.1) | 6.8 (1.6) | 10.2 (1.4) | 10.1 (1.0) | 3.5 (9) |
|
| 4.5 (6) | 13.8 (8) | 5.0 (9) | 13.1 (9) | 10.4 (7) | 25.2 (9) |
|
| 24.5 (5) | 20.2 (2.4) | 21.6 | 24.2 (2.1) | 21.6 | 45.0 (1.4) |
|
| 62.0 (1.2) | 62.0 (1.3) | 70.8 (2.1) | 70.8 (1.5) | 82.2 (1.5) | 82.2 (2.0) |
| Δ | 15.5 (7) | 14.9 (9) | — | 13.0 (5) | — | 7.5 (3) |
|
| −3.4 (1) | −3.4 (1) | −3.4 | −3.4 (1) | −3.4 | −3.4 (1) |
|
| 5 | 5 | 4 | 4 | 3 | 3 |
|
| 30.0 (2.5) | 12.7 (9) | 24.5 (2.1) | 23.2 (1.0) | 24.0 (1.3) | 10.1 (9) |
The parameters fixed in the fitting procedure are q = 1, rGdO = 2.5 Å, rGdH = 3.0 Å, aGdH = 4.0 Å, 298DGdH = 2.25 × 10−5 cm2 s−1, ER = 18 kJ mol−1, Ev = 1 kJ mol−1, and rGdH(SS) = 3.5 Å.[18]
These values were fixed considering the value obtained for Gd(HPADO3A) at pH 4.2.
Stability and protonation constants of CaII-, ZnII-, CuII- and GdIII complexes formed with HPADO3A compared with literature data on HPDO3A, BT-DO3A and DOTA ligands (298 K)
| HPADO3A | DOTA | HPDO3A | BT-DO3A | |
|---|---|---|---|---|
| I | 0.15 M NaCl | 0.1 M KCl | 0.1 M Me4NCl | 0.1 M NaCl |
| CaL | 12.13 (4) | 16.37 | 14.83 | 12.1 |
| Ca(L)H−1 | 11.50 (6) | — | — | — |
| ZnL | 17.18 (3) | 18.7 | 19.37 | 17.0 |
| Zn(L)H−1 | 10.79 (5) | 10.62 | — | — |
| *CuL | 21.53 (2) | 22.72 | 22.84 | 19.1 |
| Cu(L)H−1 | 10.55 (2) | — | — | — |
| GdL | 18.41 (2) | 24.7 | 23.8 | 18.7 |
| Gd(L)H−1 | 6.73 (4) | — | 11.36 | 9.48 |
| pGd | 16.88 | 22.09 | 18.16 | 15.63 |
Ref. 24.
Ref. 25, 0.1 M NaCl, 298 K.
Ref. 26.
Ref. 27.
pGd = −log[Gd]free, [Gd3+] = 1 μM, [L] = 10 μM, pH = 7.4 (ref. 28). *Spectrophotometry, I = [Na+] + [H+] = 0.15, [H+] ≤ 0.15 M; Gd(BzHPADO3A): log KGd(L)H = 7.08 (5); Gd(PipHPADO3A): log KGd(L)H = 6.82 (2), 0.15 M NaCl, 298 K;a 0.1 M NaCl.
Rate constants (ki) and half-lives (t1/2 = ln 2/kd) characterising the dissociation reactions of Gd(HPADO3A), Gd(DOTA), Gd(HPDO3A) and Gd(BT-DO3A) complexes at 298 K
| Gd(HPA-DO3A) | Gd(DOTA) | Gd(HP-DO3A) | Gd(BT-DO3A) | |
|---|---|---|---|---|
|
| (1.6 ± 0.1) ×10−4 | 1.8 ×10−6 | 2.9 × 10−4 | 2.8 × 10−5 |
|
| 6.41 × 10−12 | 7.28 × 10−14 | 1.15 × 10−11 | 1.35 × 10−12 |
|
| 3.00 × 107 | 2.64 × 109 | 1.67 × 107 | 1.42 × 108 |
Ref. 30, 0.15 M NaCl, 298 K.
Ref. 27, 0.1 M NaCl, 298 K.